Budesonide inhalers for COVID

PRINCIPLE and STOIC trials. 

Budesonide inhalers can be considered on a case by case basis for postive COVID cases. (Off lablel use)

DoH Bulletin summarises details of recent guidance

As always Red Whale summary breaks down the research and DoH advice into a useful guide for GPs to follow. 

  • COVID in last 14 days and ongoing symptoms
  • Positive COVID test
  • >65 or >50 with co-morbidities (as per flu vaccine list)

Up to maximum 14 days inhaler use; or if inhaler runs out; or if synmptoms run out - whichever comes first. 

Please see the full guidelines in links above and check for any recent updates to these.